An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus
about
M2e-Based Universal Influenza A VaccinesAdvancements in the development of subunit influenza vaccinesDevelopment of universal influenza vaccines based on influenza virus M and NP genes.MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 virusesAn H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in miceIdentification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin.Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cellsImmunogenicity of two FMDV nonameric peptides encapsulated in liposomes in mice and the protective efficacy in guinea pigsTargeting B cell responses in universal influenza vaccine design.Development of a heat-stable and orally delivered recombinant M2e-expressing B. subtilis spore-based influenza vaccine.Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in African green monkeys.
P2860
Q26783493-45BFFB8C-BA5D-4649-8B7A-79E4B831357DQ27010100-0F96BB21-8B2A-45E8-A2C0-D54EC9C65A98Q30355116-869465A0-364F-4DEF-BB09-51B53916F0CCQ30358935-97DDED9F-FB9C-48B1-B514-BD8D8BF31C29Q30375268-99CE62C9-D62E-46C3-8BFD-E213A4822558Q30403507-255B3D9F-B72A-4424-9ADA-78CDFE4391B5Q30428969-35EAF5E3-54CA-4281-955F-F428D3B08EBFQ30535722-D4633988-5F39-4545-B794-66CEDA1E534BQ34105207-A42B5A6F-7EFF-4111-86D8-EE714B940007Q34329409-896A94EA-6E0B-4F06-8ABD-C879AB9201BCQ34850165-0BED8CCA-B615-44FF-B496-5D97A5478047Q35540405-306E29E4-0905-4270-8266-641568D23E2DQ35886473-2329F58C-5230-44D6-AE15-4E97FC051D6AQ41644232-73DAEA3E-078E-4AEE-97BB-BB4B4D54FDFB
P2860
An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An H5N1 M2e-based multiple ant ...... with pandemic 2009 H1N1 virus
@ast
An H5N1 M2e-based multiple ant ...... with pandemic 2009 H1N1 virus
@en
type
label
An H5N1 M2e-based multiple ant ...... with pandemic 2009 H1N1 virus
@ast
An H5N1 M2e-based multiple ant ...... with pandemic 2009 H1N1 virus
@en
prefLabel
An H5N1 M2e-based multiple ant ...... with pandemic 2009 H1N1 virus
@ast
An H5N1 M2e-based multiple ant ...... with pandemic 2009 H1N1 virus
@en
P2093
P2860
P356
P1433
P1476
An H5N1 M2e-based multiple ant ...... with pandemic 2009 H1N1 virus
@en
P2093
Bo-Jian Zheng
Guangyu Zhao
Shihui Sun
Wenjun Xiao
Yuchun Lone
Yusen Zhou
Zhihua Kou
P2860
P2888
P356
10.1186/1743-422X-7-151
P577
2010-07-12T00:00:00Z
P5875
P6179
1006576552